Trials / Conditions / Pancreatic Neuroendocrine Neoplasm
Pancreatic Neuroendocrine Neoplasm
4 registered clinical trials studyying Pancreatic Neuroendocrine Neoplasm — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metast NCT06202066 | Roswell Park Cancer Institute | Phase 2 |
| Recruiting | A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET NCT06592989 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | — |
| Recruiting | Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms NCT05746182 | University of California, San Francisco | — |
| Not Yet Recruiting | Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms NCT05316480 | Fudan University | Phase 2 |